Performance

JANX -51.81%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
JANX	-27.62%	-7.54%	-51.81%	-14.08%	-64.94%	-0.49	0.00%

Summary

JANX at a glance

JANX returned -51.81% over the past year and -14.08% a year over five years. Its worst drop in that year was -64.94%, smaller than 9% of stocks on Redstone, and its Sharpe ratio of -0.49 beats 12% of stocks on Redstone. It pays no dividends.

Ranking

How JANX ranks

Current Drawdown

-63.27%

Rolling Volatility

113.29%

Actions

Metrics

Risk Indicators

Alpha-47.08%

Beta0.95x

Sharpe-0.49

Sortino-0.56

Omega0.89

Calmar-0.80

Martin-0.69

Profile

About JANX

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $780M
Listed: Jun 2021
Employees: 113
Headquarters: San Diego, CA
Website: januxrx.com

Comparisons

JANX: Janux Therapeutics, Inc.

JANX at a glance

How JANX ranks

Current Drawdown

Rolling Volatility

About JANX

Related comparisons